HCL Technologies provide FDA-compliant product to Glenmark
Mumbai, Mar 29 (UNI) HCL Technologies today announced that it has arrived at an agreement with Glenmark Pharmaceuticals Ltd (Glenmark) to implement the Company's comprehensive drug labeling framework called easy Labeling Solution.
Developed specifically for pharmaceutical companies, the Company's easy Labeling Solution will assist Glenmark to streamline drug labeling, manage product information lifecycles and comply with the US FDA (Federal Drug Administration)'s Structured Product Labeling (SPL) regulations.
Glenmark, an India-based global pharmaceutical company, will be able to leverage the Company's easy Labeling Solution for customers around the world. It is the first pharmaceutical company in India to implement an SPL compliance solution, a HCL Technologies release informed BSE.
Built on the Documentum platform, the Company's easy Labeling Solution enables content creation format through a user-friendly browser-based interface.
This enables pharmaceutical companies, like Glenmark to easily create, manage and intelligently reuse product information for regulatory filings and meet the FDA's new SPL guidelines that went into effect in June 2005, the release added.
UNI GC MAZ AW1615